H1N1 Vaccine Quantities to Fall Short of Predictions

October 2009
Pharmaceutical Representative;Oct2009, Vol. 39 Issue 10, p8
The article reports that the H1N1 influenza vaccines fall short of the predicted doses in the U.S. The vaccines were predicted to reach 120 million doses but only 45 million doses were available in the middle of October 2009 but the government plans for an additional 20 million doses. GlaxoSmithKline reveals that they are developing a vaccine and they will conduct 16 additional clinical trials while Novartis starts to distribute its seasonal influenza vaccine.


Related Articles

  • H1N1 outbreak should spur CT sites to prepare.  // Clinical Trials Administrator;Jun2009, Vol. 7 Issue 6, p63 

    The article addresses the need for clinical trial (CT) sites to be prepared with policies and procedures in response to outbreaks such as the influenza A (H1N1) virus infection. According to Edwin V. Gaffney, a clinical research consultant based in Birmingham, Alabama, CT sites must have their...

  • Rapid Selection of Oseltamivirand Peramivir-Resistant Pandemic H1N1 Virus during Therapy in 2 Immunocompromised Hosts. Memoli, Matthew J.; Hrabal, Rachel J.; Hassantoufighi, Arash; Eichelberger, Maryna C.; Taubenberger, Jeffery K. // Clinical Infectious Diseases;5/1/2010, Vol. 50 Issue 9, p1252 

    Pandemic 2009 H1N1 virus isolates containing the neuraminidase inhibitor resistance mutation H275Y have been reported. We describe rapid selection for the H275Y resistance mutation during therapy in 2 immunocompromised individuals at 9 and 14 days of therapy, as well as the first described case...

  • DATA DIVING. Grens, Kerry // Scientist;May2012, Vol. 26 Issue 5, p36 

    The article discusses the clinical trials conducted by the researchers in the U.S. on the use of Tamiflu as an antiviral medication for H1N1 influenza. It mentions the study from Peter Desbi of John Hopkins University and his colleagues which shows the insufficiency of evidence for the drug's...

  • TCM HIN1 FLU REMEDIES.  // American Herb Association Quarterly Newsletter;Fall2009, Vol. 24 Issue 4, p5 

    The article focuses on the implementation of a national program by the Education Ministry in China, in which students were given free traditional Chinese medicines as preventive medicine. The Chinese blend, Lian Hua Qing Wen, including forsythia fruit and honeysuckle flower was recommended by...

  • Chinese herbs for flu treatment. Elliott, William T. // Neurology Alert;Oct2011 Clinical Briefs, p2 

    The article discusses research on H1N1 influenza treatment, referencing a study published in the "Annals of Internal Medicine," which concludes that oseltamivir and Chinese herbs called maxingshigan-yinqiaosan, alone or in combination, decrease time-to-fever resolution in H1N1 influenza patients.

  • CME Questions.  // Infectious Disease Alert;Dec2009, Vol. 29 Issue 3, p34 

    A quiz concerning the treatment of H1N1 influenza virus infection is presented.

  • Correction: Oseltamivir Compared With Chinese Traditional Therapy.  // Annals of Internal Medicine;1/3/2012, Vol. 156 Issue 1, p71 

    A correction to the article "Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: A randomized trial" that was published in the 2011 issue is presented.

  • Timing for influenza A (H1N1) therapy remains up for debate.  // Infectious Diseases in Children;Dec2009, Vol. 22 Issue 12, p25 

    The article reports on an ongoing concern among clinicians over the recommended 48-hour window for initiating antivial therapy for the treatment of influenza A (H1N1) virus.

  • TESTING FOR H1N1. Degenstein, Tracy // Clinical Advisor;Feb2010, Vol. 13 Issue 2, p83 

    The article provides an answer to a question on whether to start a patient with a fever and dry cough on Tamiflu without testing for the H1N1 influenza.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics